SC 13G
1
FLFVSC13G0224.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Feutune Light Acquisition Corp
(Name of Issuer)
Common Stock, $0.0001 Par Value
(Title of Class of Securities)
31561T102
(CUSIP Number)
31-Dec-23
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be 'filed' for the purpose of Section 18 of the Securities
Exchange Act of 1934 ('Act') or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP No. 31561T102
----------------------------------------------------------------------
1. Names of Reporting Persons.
Barclays PLC
----------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------
3. SEC Use Only
-------------------------------------------------------------------
4. Citizenship or Place of Organization
England, United Kingdom
5. Sole Voting Power
Number of 335,000
Shares ------------------------------
Beneficially 6. Shared Voting Power
Owned by Each -0-
Reporting ------------------------------
Person With: 7. Sole Dispositive Power
335,000
------------------------------
8. Shared Dispositive Power
-0-
-------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
335,000
---------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
--------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
6.04%
-----------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
HC
---------------------------------------------------------------
CUSIP No. 31561T102
----------------------------------------------------------------
1. Names of Reporting Persons.
Barclays Capital Inc.
-----------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
---------------------------------------------------------------------
3. SEC Use Only
---------------------------------------------------------------------
4. Citizenship or Place of Organization
Connecticut, United States
5. Sole Voting Power
Number of 335,000
Shares ------------------------------
Beneficially 6. Shared Voting Power
Owned by Each -0-
Reporting ------------------------------
Person With: 7. Sole Dispositive Power
335,000
------------------------------
8. Shared Dispositive Power
-0-
---------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
335,000
---------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
---------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
6.04%
--------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
BD
-------------------------------------------------------------------
-------------------------------------------------------------------
Item 1.
(a) Name of Issuer:
Feutune Light Acquisition Corp
(b) Address of Issuer's Principal Executive Offices:
48 Bridge Street, Building A
Metuchen, New Jersey 08840
------------------------------------------------------------------
----------------------------------------------------------------
Item 2.
(a) Name of Person Filing:
(1) Barclays PLC
(2) Barclays Capital Inc.
(b) Address of Principal Business Office or, if none, Residence:
(1) Barclays PLC
1 Churchill Place,
London, E14 5HP, England
(2) Barclays Capital Inc.
745 Seventh Ave
New York, NY 10019
(c) Citizenship:
(1) Barclays PLC: England, United Kingdom
(2) Barclays Capital Inc.: Connecticut, United States
(d) Title of Class of Securities: Common Stock, $0.0001 Par Value
(e) CUSIP Number: 31561T102
----------------------------------------------------------------------
Item 3. If this statement is filed pursuant to Sub-Section 240.13d-1
(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
(a) [X] Broker or dealer registered under section 15 of
the Act (15 U.S.C. 78o);
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c) [ ] Insurance company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c);
(d) [ ] Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C. 80a-8);
(e) [ ] An investment adviser in accordance with
Sub-Section 240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with
Sub-Section 240.13d-1(b)(1)(ii)(F);
(g) [X] A parent holding company or control person in accordance with
Sub-Section 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
(j) [X] A non-U.S. institution that is the functional equivalent
of any of the institutions listed in
Rule 240.13d-1 (b)(1)(ii)(A) through (I);
(k) [ ] Group, in accordance with Sub-Section 240.13d-1(b)(1)(ii)(J).
------------------------------------------------------------------------
Item 4. Ownership.
Provide the following information regarding the
aggregate number and percentage of the class of securities
of the issuer identified in Item 1.
(a) Amount beneficially owned:
See the response(s) to Item 9 on the attached cover page(s).
(b) Percent of class:
See the response(s)to Item 11 on the attached cover page(s).
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the
attached cover page(s).
(ii) Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the
attached cover page(s).
(iii) Sole power to dispose or to direct the
disposition of:
See the response(s) to Item 7 on the
attached cover page(s).
(iv) Shared power to dispose or to direct the
disposition of:
See the response(s) to Item 8 on the
attached cover page(s).
-----------------------------------------------------------------
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact
that as of the date hereof the reporting person has ceased
to be the beneficial owner of more than five percent of the
class of securities, check the following
[ ]
---------------------------------------------------------------------
Item 6. Ownership of More than Five Percent on Behalf of
Another Person.
Not Applicable.
-------------------------------------------------------------------
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the
Parent Holding Company.
See Exhibit A.
-------------------------------------------------------------------
Item 8. Identification and Classification of Members of the Group.
Not Applicable.
--------------------------------------------------------------------
Item 9. Notice of Dissolution of Group.
Not Applicable.
--------------------------------------------------------------------
Item 10. Certification.
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to
above were acquired and are held in the ordinary
course of business and were not acquired and are
not held for the purpose of or with the effect of
changing or influencing the
control of the issuer of the securities and were not
acquired and are not held in connection
with or as a participant in any transaction
having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the
information set forth in this statement is true,
complete and correct.
Dated: February 13, 2024
By : Ramya Rao
Title: Director
--------------------------------------------------------------------
INDEX TO EXHIBITS
Exhibit A Item 7 Information
Exhibit B Joint Filing Agreement
------------------------------------------------------------------------
EXHIBIT A
The securities being reported on by Barclays PLC,
as a parent holding company,
are owned, or may be deemed to be beneficially owned,
by
Barclays Bank PLC,
a non-US banking institution registered with the Financial
Conduct
Authority
authorised by the Prudential Regulation Authority and regulated
by the Financial
Conduct Authority and the Prudential Regulation Authority in
the United Kingdom.
Barclays Bank PLC,
is a wholly-owned subsidiary of Barclays PLC.
------------------------------------------------------------------------
EXHIBIT B
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13G filed
herewith (and any amendments thereto), is being filed jointly with the
Securities and Exchange Commission pursuant to
Rule 13d-1(k) (1) under the Securities Exchange Act of 1934,
as amended, on behalf of each such person.
Dated: February 13, 2024
BARCLAYS PLC
By : Ramya Rao
Title: Director
Barclays Capital Inc.
By : Ramya Rao
Title: Director
Feutune Light Acquisition Corporation and Thunder Power Holdings Limited closed their previously announced business combination on June 21, 2024.The combined entity, Thunder Power Holdings, Inc., is expected to commence trading its common stock on Nasdaq Global Market on Monday, June 24, 2024 under the ticker symbol "AIEV". Wilmington, Delaware, June 21, 2024 (GLOBE NEWSWIRE) -- Thunder Power Holdings, Inc. (NASDAQ:AIEV), a developer of premium passenger EVs positioned to earn market share based on competitive design, quality, comfort, range, and price, today announced the successful closing of the business combination (the "Business Combination") between Thunder Power Holdings Limite
Wilmington, DE, June 18, 2024 (GLOBE NEWSWIRE) -- Feutune Light Acquisition Corporation (NASDAQ:FLFV), a special purpose acquisition company ("FLFV" or the "Company"), today announced that its previously announced business combination (the "Business Combination") with Thunder Power Holdings Limited ("Thunder Power"), was approved at a special meeting of stockholders (the "Special Meeting") of FLFV held on June 17, 2024. Approximately 95.87% of the votes cast at the Special Meeting were in favor of the Business Combination. FLFV plans to file the results of the Special Meeting, as tabulated by an independent inspector of elections, on a Current Report on Form 8-K with the Securities and Exc
Special meeting of Feutune Light Acquisition Corporation stockholders to be adjourned until June 17, 2024, at 9:00 a.m., Eastern Time Wilmington, DE, June 11, 2024 (GLOBE NEWSWIRE) -- Feutune Light Acquisition Corporation (NASDAQ:FLFV), a special purpose acquisition company ("FLFV"), today announced that it will adjourn its special meeting of stockholders (the "Special Meeting") scheduled to be held on June 11, 2024 at 9:00 am Eastern Time. The Special Meeting will be adjourned to June 17, 2024 at 9:00 a.m. Eastern Time (the "New Meeting Date"). As previously announced, the Special Meeting will occur virtually via teleconference with the same access information at: +1 813-308-9980 (acc
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint.
Takeda Pharmaceutical Co Ltd (NYSE:TAK) announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935) for the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).
AMMO shares dipped 19.1% to $2.0306 on Friday.
Here are some other stocks moving in today’s mid-day session.
Gainers
Interactive Strength Inc. (NASDAQ:TRNR) shares climbed 148% to $7.07 after dipping 19% on Friday.
Mustang Bio, Inc. (NASDAQ:MBIO) shares jumped 145% to $0.32 after the company announced safety and efficacy da